A patient presenting nasal septum perforation during bevacizumab-containing chemotherapy for advanced breast cancer

ISSN： 1340-6868

Source： Breast Cancer, Vol.18, Iss.3, 2011-07, pp. : 226-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nasal septum perforation and bevacizumab

By Power Derek

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 89-93

Humana Press, Inc

Access to resources Recommend Favorite

Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial

By Brufsky Adam

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1067-1075

Springer Publishing Company

Access to resources Recommend Favorite

Final overall survival results and effect of prolonged (≥1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial

By Smith Ian

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 133-143

Springer Publishing Company

Access to resources Recommend Favorite

Acute aortic dissection in a hypertensive patient with prostate cancer undergoing chemotherapy containing bevacizumab

By Aragon-Ching Jeanny Ning Yang-Min Dahut William

Acta Oncologica, Vol. 47, Iss. 8, 2008-01 ,pp. : 1600-1601

Informa Healthcare

Access to resources Recommend Favorite

Squamous cell carcinoma of the tongue in a female with advanced breast cancer: A case report of an elderly patient presenting with two types of cancer

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 235-237

Spandidos Publications

Access to resources Recommend Favorite